Mayo Clinic was the first medical center to use Medtronic Inc.’s (NYSE:MDT) heart tissue freezing device.
Hospital physician Dr. Douglas Packer yesterday treated an atrial fibrillation patient with the Minneapolis-based company’s Arctic Front cardiac cryoablation catheter system.
Medtronic won pre-market approval for the device from the Food & Drug Administration in December. Rochester, Minn.-based Mayo Clinic was the site of the trial that led to the device’s regulatory clearance.
The minimally invasive device is indicated for patients who don’t respond to drug treatment and uses a balloon to freeze and subsequently destroy, or "ablate," cardiac tissue that is affecting the patient’s heart rhythm.
Atrial fibrillation is the most common cardiac arrhythmia and affects more than 2 million Americans, according to Mayo Clinic.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.